Cefepime is an antimicrobial drug. It is classified under fourth generation cephalosporin antibiotics, which is often used to treat moderate to severe pneumonia and other bacterial infections. Lately, Cefepime is rarely used due to an FDA early communication regarding its safety. The article, Efficacy and Safety of Cefepime: A Systematic Review and Meta-analysis, was published in May 2007 at The Lancet Infectious Diseases. It is basically about an ongoing review of Cefepime's effectiveness against an increased mortality rate connected to its use.
Cefepime is also used to treat complicated episodes of urinary tract infections, skin infections, and intra-abdominal infections. It is also often used as an Empiric Therapy for Febrile Neutropenic Patients. The effectiveness of Cefepime over other antibacterial drugs lies in its great activity against susceptible bacteria.
Cefepime is a liquid suspension administered intravenously. It is either injected to your large muscle in the hip or in the buttock or added to an intravenous fluid dripping through your veins every 12 to 24 hours. Doctor's supervision is significant in Cefepime use because the doctor is the only one who could tell you whether it is applicable to treat your current illness or not. A patient using Cefepime treatment is also closely watched to ensure that the effectiveness of the drug is greater than its side effects. Physical examinations and laboratory testing are ordered to monitor how the patient's symptoms respond to the treatment.